{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T15:32:47Z","timestamp":1705851167867},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1988,3,1]],"date-time":"1988-03-01T00:00:00Z","timestamp":573177600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urol. Res."],"published-print":{"date-parts":[[1988,3]]},"DOI":"10.1007\/bf00261958","type":"journal-article","created":{"date-parts":[[2004,10,6]],"date-time":"2004-10-06T09:57:37Z","timestamp":1097056657000},"page":"67-72","source":"Crossref","is-referenced-by-count":15,"title":["Study of the effect of an anti-androgen (Oxendolone) on experimentally induced canine prostatic hyperplasia"],"prefix":"10.1007","volume":"16","author":[{"given":"K.","family":"Okada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Sudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kawase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1172\/JCI109532","volume":"64","author":"DP deKlerk","year":"1979","unstructured":"deKlerk DP, Coffey DS, Ewing LL, McDermott IR, Reiner WG, Robinson CH, Scott WW, Strandberg JD, Talalay P, Walsh PC, Wheaton LG, Zirkin BR (1979) Comparison of spontaneous and experimentally induced canine prostatic hyperplasia. J Clin Invest 64:842?849","journal-title":"J Clin Invest"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1530\/acta.0.1000462","volume":"100","author":"P-J Funke","year":"1982","unstructured":"Funke P-J, Tunn UW, Senge Th, Neumann F (1982) Effects of the antioestrogen tamoxifen on sterioid induced morphological and biochemical changes in the castrated dog prostate. Acta Endocrinol (Copenh) 100:462?472","journal-title":"Acta Endocrinol (Copenh)"},{"key":"CR3","first-page":"355","volume-title":"Pharmacological and biochemical properties of drug substances","author":"BJ Furr","year":"1979","unstructured":"Furr BJ, Patterson JS, Richardson DN, Slater SR, Wakeling AE (1979) Tamoxifen. In: Goldberg ME (ed) Pharmacological and biochemical properties of drug substances. American Pharmaceutical Association, New York, pp 355?399"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1248\/yakushi1947.103.10_1042","volume":"103","author":"G Goto","year":"1983","unstructured":"Goto G, Hiraga K, Miki T Sumi M (1983) An alternative synthesis of 16?-ethyl-17 ?-hydroxyestr-4-en-3-one (Oxendolone). Yakugaku Zasshi 103:1042?1045 (Japanese)","journal-title":"Yakugaku Zasshi"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1084\/jem.72.6.747","volume":"72","author":"C Huggins","year":"1940","unstructured":"Huggins C, Clark PJ (1940) Quantitative studies of the prostatic secretion. II. The effect of castration and of estrogen injection on the normal and on the hyperplastic prostate glands of dogs. J Exp Med 72:747?761","journal-title":"J Exp Med"},{"key":"CR6","first-page":"696","volume":"23","author":"C Huggins","year":"1947","unstructured":"Huggins C (1947) The etiology of benign prostatic hypertrophy. Bull NY Acad Med 23:696?704","journal-title":"Bull NY Acad Med"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1210\/endo-102-6-1748","volume":"102","author":"GH Jacobi","year":"1978","unstructured":"Jacobi GH, Moore RJ, Wilson JD (1978) Studies on the mechanism of 3?-androstanediol-induced growth of the dog prostate. Endocrinology 102:1748?1755","journal-title":"Endocrinology"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1530\/acta.0.092S036","volume":"229","author":"M Masuoka","year":"1979","unstructured":"Masuoka M, Masaki T, Yamazaki I, Hori I, Nakayama R (1979) Hormonal spectra of anti-androgen TSAA-291 (16?-ethyl-17?-hydroxy-4-oestren-3-one) and its derivatives. Acta Endocrinol (Copenh) [Suppl] 92 229:36?52","journal-title":"Acta Endocrinol (Copenh) [Suppl] 92"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1172\/JCI109536","volume":"64","author":"RJ Moore","year":"1979","unstructured":"Moore RJ, Gazak JM, Quebbeman JF, Wilson JD (1979) Concentration of dihydrotestosterone and 3?-androstanediol in naturally occuring and androgen-induced prostatic hyperplasia in the dog. J Clin Invest 64:1003?1010","journal-title":"J Clin Invest"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1530\/acta.0.092S002","volume":"229","author":"R Nakayama","year":"1979","unstructured":"Nakayama R, Masuoka M, Masaki T, Shimamoto K (1979) Antiandrogenic effect of a new steroid TSAA-291 (16?-ethyl-17 ?-hydroxy-4-oestren-3-one) and its derivatives. Acta Endocrinol (Copenh) [Suppl] 92 229:2?23","journal-title":"Acta Endocrinol (Copenh) [Suppl] 92"},{"key":"CR11","first-page":"5","volume-title":"Proceedings of the International Symposium on Medroxyprogesterone Acetate","author":"F Pannuti","year":"1982","unstructured":"Pannuti F, Martoni A, Camaggi CM, Strocchi E, Di Marco AR, Rossi AP, Tomasi L, Giovannini M, Cricca A, Fruet F, Lelli G, Giambiasi ME, Canova N (1982) High dose medroxyprogesterone acetate in oncology. History, clinical use and pharmacokinetics. In: Cavalli F, McGuire WL, Pannuti F, Pellegrini A, Robustelli Della Cuna G (eds) Proceedings of the International Symposium on Medroxyprogesterone Acetate. Excerpta Medica, Amsterdam, pp 5?43"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/acta.0.092S067","volume":"229","author":"K Sudo","year":"1979","unstructured":"Sudo K, Yoshida K, Kimura Y, Nakayama R (1979) Effect of the anti-androgen TSAA-291 on the androgen-receptor complex formation from (3H)testosterone in rat ventral prostates. Acta Endocrinol (Copenh) [Suppl] 92 229:67?81","journal-title":"Acta Endocrinol (Copenh) [Suppl] 92"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1210\/endo-97-4-825","volume":"97","author":"L Tseng","year":"1975","unstructured":"Tseng L, Gurpide E (1975) Induction of human endometrial estradiol dehydrogenase by progestins. Endocrinology 97:825?833","journal-title":"Endocrinology"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1530\/acta.0.0910373","volume":"91","author":"U Tunn","year":"1979","unstructured":"Tunn U, Senge Th, Schenck B, Neumann F (1979) Biochemical and histological studies on prostates in castrated dogs after treatment with androstanediol, oestradiol and cyproterone acetate. Acta Endocrinol (Copenh) 91:373?384","journal-title":"Acta Endocrinol (Copenh)"},{"key":"CR15","first-page":"289","volume":"18","author":"UW Tunn","year":"1980","unstructured":"Tunn UW, Schuering B, Senge Th, Neumann F, Schweikert HU, Rohr HP (1980) Morphometrical analysis of prostates in castrated dogs after treatment with androstanediol, estradiol, and cyproterone acetate. Invest Urol 18:289?292","journal-title":"Invest Urol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1172\/JCI108353","volume":"57","author":"PC Walsh","year":"1976","unstructured":"Walsh PC, Wilson JD (1976) The induction of prostatic hypertrophy in the dog with androstanediol. J Clin Invest 57:1093?1097","journal-title":"J Clin Invest"},{"key":"CR17","first-page":"1077","volume":"25","author":"O Yoshida","year":"1979","unstructured":"Yoshida O, Okada K, Shida K, Kondo A, Saito Y, Tsuji I, Kumamoto Y, Orikasa S, Shimazaki J, Mitsuya H, Kuroda K, Omori H, Nihira H, Momose S, Sakuma A (1979) Clinical evaluation of TSAA-291 in treatment of benign prostatic hyperplasia by double blind study. Acta Urol Jpn 25:1077?1108 (Japanese)","journal-title":"Acta Urol Jpn"},{"key":"CR18","first-page":"139","volume":"35","author":"O Yohida","year":"1984","unstructured":"Yohida O, Okada K (1984) Clinical effect of gestonorone caproate on prostatic hypertrophy: a double blind study. Current Ther Res 35:139?155","journal-title":"Current Ther Res"}],"container-title":["Urological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00261958.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00261958\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00261958","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T08:40:14Z","timestamp":1585903214000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00261958"}},"subtitle":["I. Morphological analysis"],"short-title":[],"issued":{"date-parts":[[1988,3]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1988,3]]}},"alternative-id":["BF00261958"],"URL":"https:\/\/doi.org\/10.1007\/bf00261958","relation":{},"ISSN":["0300-5623","1434-0879"],"issn-type":[{"value":"0300-5623","type":"print"},{"value":"1434-0879","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988,3]]}}}